Literature DB >> 8446780

Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients.

R G Geissler1, O G Ottmann, K Kleiner, U Mentzel, A Bickelhaupt, D Hoelzer, A Ganser.   

Abstract

Deficiencies in bone marrow stromal cells, i.e. fibroblasts, macrophages, endothelial cells and adipocytes, are considered to play a pathophysiological role in HIV-associated haematopoietic failure. Long-term bone marrow cultures (LTBMC) enable the longitudinal investigation of haematopoietic progenitor cell and bone marrow stromal growth. Therefore, in this study, the haematopoietic colony growth of bone marrow from patients with severe HIV infection was compared to that from healthy controls in LTBMC. The total cumulated number of colony-forming units/granulocyte-macrophage (CFU-GM) was 6.7-fold higher (293.6% vs. 44.0%, p < 0.01), that of colony-forming units/granulocyte-erythrocyte-macrophage-megakaryocyte (CFU-GEMM) was 3.5-fold higher (28.7% vs 8.3%), and that of burst-forming units/erythrocyte (BFU-E) was 31.1-fold higher (68.4% vs 2.2%) than that from HIV-positive patients, respectively (colony number before LTBMC = 100%). In contrast, the cumulated cell number at the end of LTBMC from HIV-positive patients was not reduced (cell numbers in percent of initially seeded cells: HIV-positive 418.4%, HIV-negative 397.1%). The significantly reduced colony-forming capacity over a significantly shorter time span, without reduction in the absolute cell number, in LTBMC from patients with severe HIV-infection as compared to healthy controls, suggests that uncoupling between cell proliferation and differentiation is a pathophysiological mechanism in HIV-dependent haematopoietic failure.

Entities:  

Mesh:

Year:  1993        PMID: 8446780     DOI: 10.1016/s0923-2516(06)80014-2

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  7 in total

1.  Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo.

Authors:  P S Koka; B D Jamieson; D G Brooks; J A Zack
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients.

Authors:  R G Geissler; J Muth; A Maurer; U Mentzel; M Mag; J W Engels; D Hoelzer; A Ganser
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

3.  Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease.

Authors:  Kenji Yamakami; Mitsuo Honda; Masami Takei; Yasushi Ami; Noboru Kitamura; Susumu Nishinarita; Shigemasa Sawada; Takashi Horie
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients.

Authors:  I Birgitta Sundell; Prasad S Koka
Journal:  J Stem Cells       Date:  2006

6.  Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro.

Authors:  Adam Tripp; Yingxian Liu; Michelle Sieburg; Joanne Montalbano; Stephen Wrzesinski; Gerold Feuer
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 7.  Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells.

Authors:  M C Re; G Furlini; G Zauli; M La Placa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.